Current position:Home >Product >
N-(3-chlorophenyl)-4-(8-methoxy-2-methyl-benzo[b][1,4]benzoxazepin-6-yl)-2-methyl-piperazine-1-carboxamide
N-(3-chlorophenyl)-4-(8-methoxy-2-methyl-benzo[b][1,4]benzoxazepin-6-yl)-2-methyl-piperazine-1-carboxamide
|
|
Canonical SMILES:
CC1CN(CCN1C(=O)NC2=CC(=CC=C2)Cl)C3=NC4=C(C=C(C=C4)C)OC5=C3C=C(C=C5)OC
Isomeric SMILES
CC1CN(CCN1C(=O)NC2=CC(=CC=C2)Cl)C3=NC4=C(C=C(C=C4)C)OC5=C3C=C(C=C5)OC
InChI
InChI=1S/C27H27ClN4O3/c1-17-7-9-23-25(13-17)35-24-10-8-21(34-3)15-22(24)26(30-23)31-11-12-32(18(2)16-31)27(33)29-20-6-4-5-19(28)14-20/h4-10,13-15,18H,11-12,16H2,1-3H3,(H,29,33)
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 4-(8-methoxy-2-methyl-benzo[b][1,4]benzoxazepin-6-yl)-2-methyl-N-[3-(trifluoromethyl)phenyl]piperazine-1-carboxamide
- N-tert-butyl-4-(8-methoxy-2-methyl-benzo[b][1,4]benzoxazepin-6-yl)-2-methyl-piperazine-1-carboxamide
- 4-(8-methoxy-2-methyl-benzo[b][1,4]benzoxazepin-6-yl)-2-methyl-N-(4-methylphenyl)piperazine-1-carboxamide
- 4-(8-methoxy-2-methyl-benzo[b][1,4]benzoxazepin-6-yl)-2-methyl-N-(phenylmethyl)piperazine-1-carboxamide
- N-(2-fluorophenyl)-4-(8-methoxy-2-methyl-benzo[b][1,4]benzoxazepin-6-yl)-2-methyl-piperazine-1-carboxamide
- N-(3-fluorophenyl)-4-(8-methoxy-2-methyl-benzo[b][1,4]benzoxazepin-6-yl)-2-methyl-piperazine-1-carboxamide
- 4-(8-methoxy-2-methyl-benzo[b][1,4]benzoxazepin-6-yl)-N-(2-methoxyphenyl)-2-methyl-piperazine-1-carboxamide
- N-(3,5-dimethoxyphenyl)-4-(8-methoxy-2-methyl-benzo[b][1,4]benzoxazepin-6-yl)-2-methyl-piperazine-1-carboxamide
- 6-[4-(4-tert-butylphenyl)sulfonyl-1,4-diazepan-1-yl]-10-methoxy-benzo[b][1,4]benzoxazepine
- 4-(8-methoxy-2-methyl-benzo[b][1,4]benzoxazepin-6-yl)-2-methyl-N-[(3-methylphenyl)methyl]piperazine-1-carboxamide

